MedPath

Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study

Not Applicable
Not yet recruiting
Conditions
Malnutrition (Calorie)
Stem Cell Transplant Complications
Registration Number
NCT07010068
Lead Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Brief Summary

prospective, randomized, multicenter study to confirm the potential benefits of TGF-β2 enriched FSMP. The primary objective is to evaluate the superiority of supplementing with TGF-β2 FSMP (experimental arm) compared to best supportive treatment (BST) in preventing malnutrition in patients submitted to allo-SCT. The secondary endpoints include the assessment of reduction of incidence of severe acute GVHD at day +100.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
214
Inclusion Criteria
  • Intact intestinal tract
  • Life expectancy more than 12 weeks
  • Allogeneic stem cell transplantation
  • Signed informed consent
Exclusion Criteria
  • Active hematological disease at the beginning of conditioning
  • Personal history of inflammatory bowel diseases
  • Personal history of bowel resection
  • Personal history of gastric bypass procedures
  • Enrolment in a competitive prospective study (malnutrition or GVHD as primary outcome)
  • Subjects with known hypersensitivity to milk proteins or components of Modulen-IBD

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Preventiongiven from day -7 to day +28

● PG-SGA score C (severe malnutrition) at day +28 \<50%

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.